Minimally Invasive Surgery Market

Market Definition

The Minimally Invasive Surgery Market size was valued at USD 44.90 billion in 2023 and is predicted to reach USD 71.34 billion by 2030 with a CAGR of 6.9% from 2024 to 2030. Minimally invasive surgery (MIS), also known as laparoscopic surgery or keyhole surgery, is a medical procedure that uses small incisions and specialized instruments to perform operations on the body. It is a form of surgery that involves less damage to the body than traditional open surgery.

Minimally invasive surgery is performed to reduce the wound in the body. MIS is typically performed using a laparoscope, which is a thin tube with a tiny camera and light at the end. The laparoscope is inserted through one of the incisions to allow a surgeon to see inside the body without having to make a large incision. The laparoscope is also used to guide instruments that are used to perform operations. The advantages of MIS include reduced scarring, shorter hospital stays, less risk of infection, quicker recovery time, less pain, and fewer complications.

Market Dynamics and Trends

The minimally invasive surgery market is significantly boosted due to the growing prevalence of chronic diseases such as arthritis, cardiovascular disorders, kidney diseases, and respiratory disease, worldwide. According to the World Health Organization (WHO) in 2021, cardiovascular diseases account for 17.9 million people’s deaths, followed by 9.3 million deaths by cancer, 4.1 million deaths by chronic respiratory diseases, and 2.0 million deaths by kidney disease deaths caused by diabetes. 

Moreover, the growing geriatric population across the globe is prone to chronic diseases such as cardiovascular and spinal disease. To minimize the impact of surgeries and reduce the wound and recovery time in the older population, the demand for minimally invasive surgery is increased, thereby boosting the growth of the market. 

Furthermore, technological advancements, such as the introduction of robotics and artificial intelligence to perform surgeries more precisely, are further driving the growth of the market. For instance, in November 2021, Max Hospital launched Da Vinci Xi Surgical Robot to perform robotic-assisted minimally invasive surgeries. The robot can perform surgeries replicating the surgeon’s hand movements and delivers highly magnified, 3D high-definition views of the surgical area.

However, the high cost of minimally invasive instruments that further increases the cost of treatment is the major factor driving the growth of the market. On the contrary, the introduction of advanced laparoscopic surgery and robotic technology to perform minimal invasive surgeries to minimize the risks of fatalities are expected to create ample opportunities for minimally invasive surgery market in coming years.

Market Segmentations and Scope of the Study

The minimally invasive surgery market share is segmented on the basis of service type, product type, application, technology, end-user, and region. On the basis of service type, the market is divided into laparoscopic surgery and robotic surgery. On the basis of product type, the market is classified into surgical devices, monitoring & visualization systems, laparoscopy devices, endosurgical equipment, and electrosurgical equipment. On the basis of technology, the market is classified into transcatheter surgery, laparoscopy surgery, non-visual imaging, and medical robotics. On the basis of application, the market is divided into gastrointestinal surgery, urology surgery, cosmetic surgery, orthopaedic & spine surgery, cardiac surgery, cancer surgery, obesity surgery, and others. On the basis of end-user, the market is segmented into hospitals, clinics, individual surgeons, and academic & research institutes. The regional breakdown and analysis of each of the aforesaid segments include regions comprising of North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America holds the dominant share of minimally invasive surgery market and is expected to continue its dominance during the forecast period. This is attributed to factors such as the growing prevalence of chronic diseases, such as cancer and obesity in countries such as the U.S. and Canada coupled with the growing demand for advanced medical treatments. According to American Cancer Society Inc, an estimated 1.9 million new cancer cases were diagnosed and 608,570 cancer deaths were recorded in the U.S. in 2021. 

Moreover, the presence of key market players, such as Stryker Corporation and CONMED Corporation, plays a major role in the development of minimally invasive surgery market in this region. For instance, in February 2022, Stryker launched PROstep MICA SOLO Guide to simplify minimally invasive bunion procedures. Through this launch, the company aims to eliminate the need for additional surgical assistance during the operation by a solo surgeon.

On the other hand, Asia Pacific is expected to show a steady rise in the minimally invasive surgery market during the forecast period. This is attributed to factors such as rapidly improving healthcare infrastructure in emerging economies such as China, India, and Japan. With the growing healthcare infrastructure, more advanced technologies including minimally invasive surgeries are being introduced in this region. According to the government of India’s Niti Aayog, healthcare is one of the largest sectors of the Indian economy and reached USD 372 billion in 2022. 

Moreover, the growing geriatric population being more prone to chronic diseases along with the increasing government initiatives to promote minimally invasive surgery is further driving the growth of minimally invasive surgery market. According to the Statistics Bureau of Japan, the elderly population above the age of 65 years old or over was 36.21 million, constituting 28.9 percent of the total population in Japan in 2021.

Competitive Landscape

The market players operating in the minimally invasive surgery market include Stryker Corporation, Conmed Corporation, Intuitive Surgical Inc., NuVasive Inc., Fortimedix Surgical BV, Microline Surgical Inc., Cirtec Medical Corp., OmniGuide Holding Inc., SeaSpine Holdings Corporation, Eximis Surgical Inc., B. Braun Melsungen AG, Medtronic Plc, Johnson & Johnson Services Inc., Abbott Laboratories, Zimmer Biomet, Koninklijke Philips NV, Silex Medical LLC, Freudenberg Medical, BEMA MEDICAL, Siemens Healthineers, and others. These market players are adopting various strategies such as new product launches to maintain their dominance in the market.

For instance, in December 2022, Abbott launched a new minimally invasive device, “Transcatheter Aortic Valve Implantation (TAVI) System Navitor” for minimally invasive surgery. Through this launch, the company aims to treat heart valve diseases such as aortic stenosis, which is one of the most common and life-threatening heart valve diseases. 

Also, in October 2022, SeaSpine Holdings Corporation launched the 7D FLASH Navigation System Percutaneous Spine Module. The new system optimizes based on the severity of the surgery including mini-open procedures and large revision surgeries. 

Moreover, in October 2022, Philips launched its minimally invasive surgical solution ClarifEye augmented reality surgical navigation. Through this launch, the company aims to provide innovative 3D AR solutions to increase the accuracy of pedicle screw placement during minimally invasive procedures. 

KEY BENEFITS

• The report provides quantitative analysis and estimations of the minimally invasive surgery market from 2024 to 2030, which assists in identifying the prevailing market opportunities.

• The study comprises a deep dive analysis of the minimally invasive surgery market including the current and future trends to depict prevalent investment pockets in the market.

• Information related to key drivers, restraints, and opportunities and their impact on the minimally invasive surgery market is provided in the report. 

• Competitive analysis of the players, along with their market share is provided in the report.

• SWOT analysis and Porters Five Forces model is elaborated in the study.

• Value chain analysis in the market study provides a clear picture of roles of stakeholders.

KEY MARKET SEGMENTS

By Service Type 

• Laparoscopic Surgery 

• Robotic Surgery

By Product Type

• Surgical Devices

• Monitoring and Visualization Systems

• Laparoscopy Devices

• Endosurgical Equipment 

• Electrosurgical Equipment

By Technology 

• Transcatheter Surgery

• Laparoscopy Surgery

• Non-Visual Imaging

• Medical Robotics

By Application 

• Gastrointestinal Surgery

• Urology Surgery

• Cosmetic Surgery

• Orthopaedic & Spine Surgery

• Cardiac Surgery

• Cancer Surgery

• Obesity Surgery

• Others

By End-User 

• Hospitals

• Clinics

• Individual Surgeons

• Academic & Research Institutes

• Others

By Region

• North America

  • The U.S.

  • Canada

  • Mexico

• Europe

  • The UK

  • Germany

  • France        

  • Italy        

  • Spain        

  • Denmark        

  • Netherlands        

  • Finland        

  • Sweden        

  • Norway        

  • Russia        

  • Rest of Europe    

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Singapore

  • Taiwan

  • Thailand

  • Rest of Asia Pacific

• RoW

  • Latin America

  • Middle East

  • Africa

REPORT SCOPE AND SEGMENTATION:

Parameters	Details
Market Size in 2023	USD 44.90 Billion
Revenue Forecast in 2030	USD 71.34 Billion
Growth Rate	CAGR of 6.9% from 2024 to 2030
Analysis Period	2023–2030
Base Year Considered	2023
Forecast Period	2024–2030
Market Size Estimation	Billion (USD)
Growth Factors	The growing prevalence of chronic diseases worldwide The growing geriatric population across the globe Technological advancements, such as the introduction of robotics and artificial intelligence to perform surgeries
Countries Covered	28
Companies Profiled	20
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.

KEY PLAYERS

• Stryker Corporation

• Conmed Corporation

• Intuitive Surgical Inc.

• NuVasive Inc.

• Fortimedix Surgical BV

• Microline Surgical Inc.

• Cirtec Medical Corp.

• OmniGuide Holding Inc.

• SeaSpine Holdings Corporation

• Eximis Surgical Inc.

• B. Braun Melsungen AG

• Medtronic Plc

• Johnson & Johnson Services Inc.

• Abbott Laboratories

• Zimmer Biomet

• Koninklijke Philips NV

• Silex Medical LLC

• Freudenberg Medical LLC

• BEMA MEDICAL

• Siemens Healthineers AG